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Allan-Herndon-Dudley syndrome (AHDS), a severe form of psychomotor retardation with abnormal thyroid 
hormone (TH) parameters, is linked to mutations in the TH-specific monocarboxylate transporter MCT8. 
In mice, deletion of Mct8 (Mct8 KO) faithfully replicates AHDS-associated endocrine abnormalities; how-
ever, unlike patients, these animals do not exhibit neurological impairments. While transport of the active 
form of TH (T3) across the blood-brain barrier is strongly diminished in Mct8 KO animals, prohormone (T4) 
can still enter the brain, possibly due to the presence of T4-selective organic anion transporting polypeptide 
(OATP1C1). Here, we characterized mice deficient for both TH transporters, MCT8 and OATP1C1 
(Mct8/Oatp1c1 DKO). Mct8/Oatp1c1 DKO mice exhibited alterations in peripheral TH homeostasis that were 
similar to those in Mct8 KO mice; however, uptake of both T3 and T4 into the brains of Mct8/Oatp1c1 DKO 
mice was strongly reduced. Evidence of TH deprivation in the CNS of Mct8/Oatp1c1 DKO mice included highly 
decreased brain TH content as well as altered deiodinase activities and TH target gene expression. Consistent 
with delayed cerebellar development and reduced myelination, Mct8/Oatp1c1 DKO mice displayed pronounced 
locomotor abnormalities. Intriguingly, differentiation of GABAergic interneurons in the cerebral cortex was 
highly compromised. Our findings underscore the importance of TH transporters for proper brain develop-
ment and provide a basis to study the pathogenic mechanisms underlying AHDS.
Introduction
Monocarboxylate transporter 8 (MCT8) is a specific thyroid hor-
mone (TH) transporter that facilitates the passage of the prohor-
mone 3,3′,5,5′-tetraiodothyronine (T4; also known as thyroxine) 
and the receptor active form, 3,3′,5-triiodothyronine (T3), across 
the plasma membrane (1). MCT8 is encoded by SLC16A2 (hereaf-
ter MCT8) located on human chromosome Xq13.2. Inactivating 
mutations and deletions in MCT8 result in a distinct clinical pic-
ture known as Allan-Herndon-Dudley syndrome (AHDS) (2–5).
All affected patients manifest a severe form of psychomotor retar-
dation composed of central hypotonia, spastic tetraplegia, lack of 
speech development, severe intellectual deficits, and global devel-
opmental delays. In addition to the pronounced neurological symp-
toms, patients exhibit characteristic changes in the serum TH pro-
file, with highly elevated T3 and lowered T4 concentrations. Since 
2004, more than 45 families with 125 affected individuals have 
been reported in the literature, and 1% of cases with the diagnosis 
of X-linked mental retardation have been estimated to be associated 
with mutations in MCT8 (6). However, by which pathogenic mecha-
nisms MCT8 deficiency causes AHDS remains largely unknown.
MCT8 is present in many organs, such as liver, kidneys, pituitary, 
and thyroid gland, and is also widely expressed in the CNS. Studies 
in mouse and human brain tissues revealed MCT8 expression in 
distinct neuronal populations, with the highest mRNA levels in 
neo- and allocortical structures (e.g., cerebral cortex, hippocam-
pus, and amygdala) as well as in hypothalamic neuroendocrine 
nuclei (e.g., paraventricular nucleus [PVN]). In addition, MCT8 is 
found in tanycytes, in choroid plexus structures, and in capillary 
endothelial cells of the blood-brain barrier (BBB) (7–10). In light 
of its localization, it has been speculated that MCT8 deficiency 
compromises the uptake of TH into brain cells, thereby interfering 
with proper neural migration and differentiation processes during 
critical stages of brain development.
To get further insight into the pathophysiological role of MCT8, 
mice with deletion of Mct8 have been generated and extensively 
studied (9, 11, 12). These Mct8 KO animals fully replicated the 
abnormalities in circulating TH concentrations in AHDS patients 
and showed a thyrotoxic situation in the liver and kidneys (13). In 
contrast to AHDS patients, Mct8 KO mice did not exhibit any overt 
neurological symptoms. This observation was rather unexpected, 
as in vivo transport studies have revealed highly diminished T3 
uptake into the brains of Mct8 KO mice (12, 14). However, T4 
transport into the CNS was only partially compromised in these 
animals. Likewise, Mct8 KO mice displayed only a moderate reduc-
tion in brain T3 content, a consequence of a rise in astrocytic type 
2 deiodinase (D2) activities, and thus enhanced local T4-to-T3 
conversion. It would therefore appear that mice express another 
T4-specific transporter that maintains almost normal passage of 
T4 across the BBB and/or the blood-CSF barrier (BCSFB) in the 
absence of MCT8. The mouse brain would consequently be much 
less affected by MCT8 deficiency than the human CNS, in which 
such an alternative route for T4 may not exist.
Which transporter can replace MCT8 in the mouse brain? Organ-
ic anion transporting polypeptide 1c1 (OATP1C1; also known as 
OATP14 or OATP-F), encoded by Slco1c1 (hereafter Oatp1c1), is an 
intriguing candidate. This transporter accepts preferentially T4 as 
well as reverse T3 as substrates (15). In mice, OATP1C1 expres-
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sion is restricted to the CNS, where it is predominantly localized 
in capillary endothelial cells as well as in choroid plexus struc-
tures (16, 17). Most interestingly, OATP1C1 protein could not be 
detected in BBB endothelial cells isolated from the primate brain 
(18). This observation is supported by immunohistochemical 
studies that documented only weak expression of OATP1C1 in 
capillary endothelial cells in human brain sections (8). Thus, the 
pronounced expression of OATP1C1 at the BBB and BCSFB of the 
murine CNS may be the reason for the rather mild brain pheno-
type of MCT8-deficient mice.
In order to test this hypothesis, we recently generated Oatp1c1 
KO mice (19). These animals develop indistinguishably from WT 
littermates and do not show any changes in serum TH levels or 
peripheral TH action. However, the brains of Oatp1c1 KO mice are 
characterized by moderately decreased T4 and normal T3 con-
tent, which indicates that OATP1C1 contributes markedly to the 
uptake of T4 into the murine CNS.
Here, we report the generation and analysis of mice with double 
KO of Mct8 and Oatp1c1 (referred to herein as Mct8/Oatp1c1 DKO 
mice). In accordance with our hypothesis, these animals exhib-
ited strongly reduced T4 uptake into the CNS that in turn led 
to a severe form of CNS-specific hypothyroidism and abnormal 
neuronal differentiation. Based on our findings we propose that 
the Mct8/Oatp1c1 DKO mouse represents the most suitable animal 
model available to date for studying human MCT8 deficiency and 
testing therapeutic interventions.
Results
Generation of Mct8/Oatp1c1 DKO mice. For the generation of mouse 
mutants deficient in MCT8 and OATP1C1, Mct8 KO mice (12) 
were mated with Oatp1c1 KO animals (19). Heterozygous offspring 
of the first generation were intercrossed, producing WT, Mct8 KO, 
Oatp1c1 KO, and Mct8/Oatp1c1 DKO animals (Supplemental Fig-
ure 1A; supplemental material available online with this article; 
doi:10.1172/JCI70324DS1). WT, single-mutant, and double-
mutant mice were born with the expected Mendelian frequency 
and were indistinguishable from each other during the first 
2 weeks of postnatal development. Daily recording of body weight 
revealed significantly reduced body weight in Mct8/Oatp1c1 DKO 
mice starting from P17 (Supplemental Figure 1B). The growth 
delay persisted after weaning and resulted in a 15%–20% decrease 
in body weight of adult Mct8/Oatp1c1 DKO mice compared with 
WT and single-mutant animals (Supplemental Figure 1C). The 
growth retardation, however, did not compromise the animals’ 
fertility. Female and male Mct8/Oatp1c1 DKO mice reproduced 
normally with a regular litter size.
Analysis of the hypothalamus-pituitary-thyroid (HPT) and somatotropic 
axes. Determination of serum TH concentrations in P21 animals 
revealed similarly elevated serum T3 and decreased T4 values in 
Mct8 KO and Mct8/Oatp1c1 DKO mice (Figure 1), which indicated 
that Mct8/Oatp1c1 DKO animals show the same abnormalities in 
the serum thyroid state as do Mct8 KO mice. Moreover, concentra-
tions of serum thyroid-stimulating hormone (TSH; encoded by 
Tshb) tended to be even more increased in Mct8/Oatp1c1 DKO mice 
than in Mct8 KO mice (Figure 1), although Tshb transcript levels 
were similarly elevated in both mouse models (Figure 2B). These 
changes may be due to a rise in hypothalamic thyrotropin-releasing 
hormone (Trh) expression, which was previously observed in Mct8 
KO animals (12). In fact, in situ hybridization (ISH) analysis of P21 
animals revealed even higher Trh-specific signal intensities in Mct8/
Oatp1c1 DKO PVN than in Mct8 KO PVN (Figure 2, A and B).
In order to study the postnatal differentiation process of the HPT 
axis in more detail, we examined hypothalamic Trh as well as pitu-
itary Tshb and D2 transcript levels at P6, P12, P21, and P33 by ISH. 
Significantly elevated Trh transcript levels were already detected in 
Mct8/Oatp1c1 DKO animals at P6 (Figure 2B), which indicated that 
in the absence of both TH transporters, Trh-expressing neurons are 
already in a pronounced hypothyroid state during early stages of 
postnatal development. Surprisingly, pituitary Tshb expression was 
significantly reduced in Mct8/Oatp1c1 DKO mice at P6, but signifi-
cantly elevated at later time points. Moreover, compared with the 
single-mutant and WT animals, D2 expression was slightly elevated 
in Mct8/Oatp1c1 DKO mice at P6, whereas at P21, no significant dif-
ferences between Mct8 KO and Mct8/Oatp1c1 DKO mice were noted 
by ISH or by activity measurements (Supplemental Figure 2A and 
Supplemental Figure 3A). These results indicated that combined 
MCT8 and OATP1C1 deficiency leads to deranged development of 
the HPT axis by early postnatal time points.
Since Mct8/Oatp1c1 DKO mice were growth retarded, we specu-
lated that the somatotropic axis may also be affected in Mct8/ 
Figure 1
Abnormal serum TH and TSH concentrations in Mct8/Oatp1c1 DKO 
mice. Serum samples of 8 animals per genotype were analyzed at P21 
and revealed increased T3 and decreased T4 serum levels in Mct8/
Oatp1c1 DKO mice (M/O DKO) as well as in Mct8 KO mice, whereas 
Oatp1c1 KO mice did not exhibit any alterations in serum TH param-
eters. Serum TSH concentrations were elevated in Mct8 KO mice and 
even more so in Mct8/Oatp1c1 DKO animals, which suggests that 
in the absence of both TH transporters, the HPT abnormalities char-
acteristic of Mct8 deficiency are even more pronounced. *P < 0.05, 
**P < 0.01, ***P < 0.001 vs. WT, or as otherwise indicated (brackets).
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Oatp1c1 DKO mice. In line with a normal growth curve within the 
first postnatal weeks, analysis of pituitary growth hormone (Gh) 
mRNA expression by ISH did not reveal any differences at P6 and 
P12 (Supplemental Figure 2C). However, at P21 (i.e., around the 
time when Mct8/Oatp1c1 DKO growth retardation became evi-
dent), pituitary Gh expression as well as hepatic Igf1 expression was 
reduced in Mct8/Oatp1c1 DKO mice (Supplemental Figure 3A). 
Moreover, ISH analysis revealed a drop in expression of hypotha-
lamic growth hormone–releasing hormone (Ghrh) in Mct8/Oatp1c1 
DKO mice, whereas hypothalamic somatostatin (Sst) expression was 
not altered (Supplemental Figure 3A). Therefore, we hypothesized 
that in the absence of MCT8 and OATP1C1, the decreased pituitary 
Gh expression is reflective of reduced GHRH stimulation.
TH metabolism and action in liver and kidneys. In order to determine 
whether Mct8/Oatp1c1 DKO mice exhibit the same alterations in 
peripheral TH metabolism as do Mct8 KO mice, we analyzed the 
expression of renal and hepatic type 1 deiodinase (D1) at P21. 
Again, Mct8/Oatp1c1 DKO and Mct8 KO mice showed similarly 
elevated D1 transcript levels in the liver and kidneys, as assessed by 
ISH and quantitative real-time PCR (qPCR; Supplemental Figure 
3, B and C). Since D1 is positively regulated by T3, these increased 
D1 mRNA values pointed to a hyperthyroid situation in these tis-
sues. This possibility was further supported by the determination 
of hepatic expression of another gene whose product is positively 
regulated by T3, α glycerol-3-phosphate dehydrogenase (Gpd2), 
which also exhibited increased transcript levels in Mct8 KO and 
Mct8/Oatp1c1 DKO mice (Supplemental Figure 3C). Together, 
these data indicated that in peripheral tissues, Mct8/Oatp1c1 DKO 
mice fully replicate the abnormalities in TH metabolism and 
action that were previously reported in Mct8 KO animals (11–13).
In vivo T4 transport studies. We previously demonstrated by in vivo 
transport studies that the uptake of i.p. [125I]T3 into the mouse 
brain was strongly diminished in the absence of MCT8, whereas 
the transport of [125I]T4 was only mildly affected (12). Here, we 
repeated the transport studies by injecting at least 3 adult animals 
per time point and genotype with 1.2 μCi [125I]T4 i.p. At given time 
points, the amount of radioactivity in the brain, liver, kidneys, 
and blood samples was determined by a γ counter and expressed 
as percentage of the injected dose per gram tissue. No differences 
among the 4 genotypes were detected in blood and liver samples 
(Figure 3A), which indicates that neither the absence of MCT8 nor 
the lack of OATP1C1 affected T4 transport in the blood and into 
the liver. In the kidneys, Mct8 KO and Mct8/Oatp1c1 DKO mice 
showed a significantly increased accumulation of radioactivity, 
thereby confirming previous findings in Mct8 KO animals (13). In 
both Mct8 KO and Oatp1c1 KO mice, accumulation of radioactiv-
ity in the CNS was reduced to approximately 50% of WT levels, 
which suggested that both transporters contribute equally to the 
passage of T4 into the brain. Most interestingly, uptake of T4 into 
the brain was strongly reduced in Mct8/Oatp1c1 DKO mice. Thus, 
these animals would consequently be expected to display a severe 
state of hypothyroidism specifically in the CNS.
Analysis of TH content and metabolism in the brain. In order to 
determine brain TH content, we intracardially perfused P21 ani-
mals with PBS, after which forebrains and cerebella were collect-
ed and processed as described previously (19). In agreement with 
Figure 2
Postnatal development of the 
hypothalamus-pituitary axis. 
Brains and pituitaries from 
male animals (n = 4 per geno-
type) were collected at different 
postnatal time points. Hypotha-
lamic Trh and pituitary Tshb 
expression were assessed by 
ISH. (A) Darkfield illuminations 
of brain sections derived from 
P21 animals illustrated the 
increase in Trh and Tshb signal 
intensities in Mct8 KO versus 
Oatp1c1 KO and WT mice. Trh 
expression was even further 
upregulated in Mct8/Oatp1c1 
DKO animals. Scale bars: 
250 μm (Trh), 1 mm (Tshb). (B) 
This optical impression was 
confirmed by quantification 
of relative signal intensities. 
*P < 0.05, **P < 0.01, ***P < 0.001 
vs. WT, or as otherwise indi-
cated (brackets).
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previous observations, Mct8 KO and Oatp1c1 KO mice exhibited 
an approximately 50% reduction in forebrain T4 levels compared 
with WT animals, whereas forebrain T3 concentrations were only 
mildly decreased in Mct8 KO mice and not altered in Oatp1c1 KO 
animals. However, forebrain T4 and T3 values were strongly 
reduced in Mct8/Oatp1c1 DKO mice, accounting for only 10% of 
WT levels (Figure 3B).
The highly reduced TH concentration in Mct8/Oatp1c1 DKO 
brains should lead to pronounced alterations in D2 and type 3 
deiodinase (D3) activities, as these are negatively and positively 
regulated, respectively, by TH. Indeed, evaluation of D2 activities 
in forebrain and cerebellum of P21 animals revealed the highest 
activities in Mct8/Oatp1c1 DKO mice, with an almost 10-fold rise 
compared with WT animals (Figure 4A). Forebrain and cerebellar 
D3 activities were decreased to a similar extent in Mct8/Oatp1c1 
DKO and Mct8 KO mice (Figure 4B). We also included brain 
tissue from athyroid Pax8 KO mice (which do not produce any 
TH endogenously; ref. 20) collected at P21, and found that the 
D2 and D3 activities in forebrain and cerebellum homogenates 
derived from Mct8/Oatp1c1 DKO and Pax8 KO mice were very 
similar (Figure 4, A and B).
Expression analysis of T3-regulated target genes in the CNS. For moni-
toring cell-specific changes in T3 concentrations, extensive ISH 
studies were performed in order to determine the expression 
levels of well-established T3 target genes. Frontal brain sections 
of P21 animals were hybridized with radioactively labeled cRNA 
probes specific for hairless (Hr), neurogranin (RC3), and alde-
hyde dehydrogenase 1a1 (Aldh1a1), all of which are known to be 
positively regulated by T3 (21, 22). In addition, we included D2 
in our analysis as a prominent example of a negatively regulated 
gene. Finally, we examined the transcript levels of mu-crystallin 
(Crym), which encodes an established intracellular TH-binding 
protein (23, 24). Hr-specific ISH signals were slightly reduced in 
cortical areas of Mct8 KO animals and strongly decreased in the 
cerebral cortex of Mct8/Oatp1c1 DKO mice (Figure 5A). Expres-
sion of RC3, which is controlled by T3 specifically in the striatum, 
was strongly downregulated in striatal neurons of Mct8/Oatp1c1 
DKO animals. Likewise, Aldh1a1-specific ISH signals were very low 
in cortical and hippocampal regions of Mct8/Oatp1c1 DKO mice, 
whereas endothelial expression of Aldh1a1 remained unaltered in 
all mutant animals. In contrast, D2 ISH signals were visibly elevat-
ed throughout the brain only in the absence of both TH transport-
ers. Even expression of Crym — which is highly enriched in distinct 
neurons of the hippocampus, cortex, and striatum — appeared to 
be increased in Mct8/Oatp1c1 DKO animals (Figure 5A), which sug-
gested that this TH-binding protein is negatively regulated by T3.
In order to validate these ISH findings, we performed qPCR 
analysis using whole forebrain samples of P21 animals. In addi-
tion to Mct8 KO, Oatp1c1 KO, Mct8/Oatp1c1 DKO, and WT ani-
mals, we again included Pax8 KO mice in our analysis. Inactiva-
tion of MCT8 and/or OATP1C1 led to significantly reduced Hr 
and RC3 transcript levels; the most prominent of these effects 
were observed in Mct8/Oatp1c1 DKO mice (Figure 5B), thereby 
confirming the ISH results. The same, however, did not apply for 
Figure 3
Strongly diminished uptake of T4 into the brain in the 
absence of MCT8 and OATP1C1. (A) For in vivo trans-
port studies, adult animals (n = 3 per genotype and 
time point) were injected i.p. with 1.2 μCi [125I]T4. A 
blood sample was obtained, after which animals were 
perfused with PBS, and brains, livers, and kidneys were 
collected. The amount of radioactivity was expressed 
as percentage of the injected dose per gram of tissue. 
Whereas the amount of radioactivity in blood and liver 
samples did not differ among mutant groups, Mct8 
KO and Mct8/Oatp1c1 DKO mice showed increased 
renal radioactivity at all analyzed time points. Most 
importantly, transport of radiolabeled T4 into the brain 
was strongly diminished in Mct8/Oatp1c1 DKO mice, 
whereas in the single-mutant animals, T4 uptake was 
reduced to approximately 50% of the respective WT 
levels. #P < 0.05, Mct8 KO vs. WT; §P < 0.05, Mct8/
Oatp1c1 DKO vs. WT; ‡P < 0.05, Oatp1c1 KO vs. WT. 
(B) Animals at P21 (n = 8 per genotype) were perfused 
with PBS before forebrains were collected for determin-
ing tissue TH concentrations. The concomitant inactiva-
tion of both TH transporters resulted in a pronounced 
decline of both T3 and T4 to approximately 10% of the 
levels in WT animals, which indicated that only Mct8/
Oatp1c1 DKO mice exhibit a severe hypothyroid state 
in the CNS. ***P < 0.001 vs. WT, or as otherwise indi-
cated (brackets).
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Crym: qPCR analysis revealed only slightly elevated transcript lev-
els in Mct8/Oatp1c1 DKO mice, despite a pronounced increase in 
ISH signal intensities in distinct brain areas. This indicated that 
Crym expression is only altered in selected neuronal populations 
under hypothyroid conditions. Interestingly, for all genes analyzed 
in this study, no differences were detected between Mct8/Oatp1c1 
DKO mice and Pax8 KO animals (Figure 5B), a finding that under-
scored the severity of the hypothyroidism in the CNS of Mct8/
Oatp1c1 DKO animals.
Delayed cerebellar development in Mct8/Oatp1c1 DKO mice. To study 
the effect of combined MCT8 and OATP1C1 deficiency on neural 
development, we histochemically monitored the maturation of dif-
ferent brain areas during postnatal development. Sagittal vibratome 
sections through the cerebellar vermis were immunostained with an 
antibody against calbindin D28 (CB), which allows for visualization 
of Purkinje cells (PCs). PC dendritogenesis, a differentiation process 
whose dependence on proper TH supply has been well established 
(25), takes place in rodents within the first 3 postnatal weeks. PCs 
displayed poor arborization and reduced dendritic growth in sec-
tions derived from P12 Mct8/Oatp1c1 DKO animals, whereas the 
morphology of PCs derived from Mct8 KO and Oatp1c1 KO ani-
mals was not altered (Supplemental Figure 4A). However, at P33 
and P120, differences in PC morphology were no longer observed 
in Mct8/Oatp1c1 DKO mice. Quantification of the thickness of the 
molecular layer that is primarily determined by the dimension of 
the PC dendritic tree confirmed the immunohistochemical observa-
tions: only at P12 was significantly reduced thickness of the molecu-
lar layer noted in Mct8/Oatp1c1 DKO mice.
Myelination is permanently compromised in Mct8/Oatp1c1 DKO mice. 
Formation of myelin is another maturation process in the CNS 
that is compromised under hypothyroid conditions (26). TH has 
been shown to promote myelination by inducing the expression 
of proteins such as myelin basic protein (MBP) (27). In order to 
assess the effect of combined MCT8 and OATP1C1 deficiency on 
the development of white matter tracts, coronal vibratome fore-
brain sections were stained with FluoroMyelin, a dye that specifi-
cally labels mature myelin sheaths. Signal intensities were visibly 
lower in the corpus callosum (cc) of Mct8/Oatp1c1 DKO mice com-
pared with single-mutant and WT animals (Figure 6A). Quantifi-
cation of the signal intensities in the cc area confirmed the optical 
impression, revealing significantly reduced values in Mct8/Oatp1c1 
DKO mice at P33 and P120. As a further approach to visualizing 
myelinogenesis, consecutive brain sections were immunostained 
with an antibody against MBP. Immunofluorescence signal inten-
sities in the cerebral cortex were quantified, which showed signifi-
cantly decreased MBP levels in Mct8/Oatp1c1 DKO mice at all time 
points. These data indicated that the formation and maturation 
of myelin sheaths is indeed reduced in the combined absence of 
MCT8 and OATP1C1.
In order to elucidate the myelination status in closer detail, 
ultrathin brain sections of P21 WT, Mct8/Oatp1c1 DKO, and Pax8 
KO mice were processed for transmission EM, and the white mat-
ter area comprising the cc at the level of the cingulum bundle was 
analyzed. WT animals exhibited ubiquitous myelination, whereas 
Mct8/Oatp1c1 DKO and Pax8 KO mice showed a patchy myelina-
tion pattern, with many axons remaining unmyelinated (Figure 6B). 
However, higher magnification revealed a normal ultrastructure of 
the myelin sheaths of those axons that were myelinated (Figure 6B). 
The reduced number of myelinated axons may affect the thickness 
of white matter regions. In order to address this possibility, we per-
formed myelin Gallyas silver impregnation as well as axonal Biel-
schowsky silver stainings on coronal paraffin sections at P21 and 
P180 and quantified cc thickness at the level of the cingulum bundle 
(Figure 6C and Supplemental Figure 4B). At both time points, the 
width of the cc was significantly reduced in Mct8/Oatp1c1 DKO mice 
by both staining methods, which indicated that overall myelin con-
tent is permanently reduced in the absence of both TH transport-
ers. Similarly, the size of another major brain white matter tract, the 
anterior commissure, was reduced in Mct8/Oatp1c1 DKO animals, 
albeit to a lesser extent than in the cc (data not shown).
Neuronal differentiation is impaired in the cerebral cortex of Mct8/ 
Oatp1c1 DKO mice. Formation and maintenance of not only the cer-
Figure 4
Effect of combined MCT8 and OATP1C1 
deficiency on TH metabolism in the CNS. 
(A) Activities of the TH activating enzyme 
D2, separately measured in forebrain 
and cerebellar homogenates of animals 
at P21 (n = 6 per genotype), revealed 
a more than 10-fold elevation in Mct8/ 
Oatp1c1 DKO mice, similar to that in 
athyroid Pax8 KO mice. (B) Determina-
tion of D3 enzymatic activities unveiled 
a similar reduction in Mct8 KO, Pax8 
KO, and Mct8/Oatp1c1 DKO animals, 
whereas D3 activities were not signifi-
cantly altered in Oatp1c1 KO animals. 
**P < 0.01, ***P < 0.001 vs. WT, or as 
otherwise indicated (brackets).
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ebellar cortex, but also the cerebral cortex, depends on proper TH 
supply during pre- and postnatal stages. In particular, the differen-
tiation of GABAergic interneurons has been shown to be delayed 
in hypothyroid rats, as evidenced by reduced parvalbumin (PV) 
immunoreactivity (28, 29). We therefore wondered whether similar 
alterations also occur in Mct8/Oatp1c1 DKO mice and performed 
immunohistochemical staining for the calcium-binding proteins 
PV, calretinin (CR), and CB, which serve as distinct markers for spe-
cific subgroups of cortical interneurons. In addition, we included 
antibodies against glutamate decarboxylase 67 (GAD67) in our 
studies, which allows for visualization of all GABAergic interneu-
rons. NeuN immunoreactivity was used to label all mature neurons. 
Similar results were obtained in the somatosensory cortex (Figure 7) 
as well as the motor and the cingulate cortex (data not shown).
Quantification of the immunohistochemical stainings at P33 
revealed a significantly reduced number of PV-positive neurons in 
the somatosensory cortex of Mct8/Oatp1c1 DKO mice at all ana-
lyzed time points (Figure 7A). Moreover, GAD67 immunoreactiv-
ity was found to be significantly decreased in Mct8/Oatp1c1 DKO 
mice as well (Figure 7B). The reduction in GAD67 immunoreac-
tivity was detected with 2 different antibodies, thereby excluding 
epitope-specific effects. This observation was surprising, since pre-
vious studies in hypothyroid animals as well as in TRα1-mutant 
animals have not revealed alterations in cortical GAD67 expres-
sion (29, 30). In contrast, CB immunoreactivity was decreased in 
Mct8/Oatp1c1 DKO mice only at P12; no alterations were ascer-
tained among genotypes at P33 and P120 (Supplemental Figure 
5A). A significantly increased abundance of CR-positive neurons 
Figure 5
Consequences of combined 
MCT8 and OATP1C1 deficiency 
on T3 target gene expression in 
the CNS. (A) ISH studies per-
formed using brain sections at P21 
(n = 4 per genotype) revealed for 
Mct8/Oatp1c1 DKO mice a strong 
downregulation in the signal inten-
sities for Hr, RC3, and Aldh1a1, all 
known to be positively regulated 
by T3. Hr expression was most 
prominently decreased throughout 
the cerebral cortex, whereas RC3 
expression was highly reduced in 
neurons of the striatum. In cortical 
areas, Aldh1a1-specific ISH sig-
nals were specifically reduced in 
astrocytes, but relatively unaltered 
in capillary endothelial cells. Dark-
field autoradiograms also illustrat-
ed upregulation of D2 in glial cells. 
Interestingly, mRNA expression of 
Crym, an intracellular TH binding 
protein, was elevated specifically 
in the cortex and striatum. Scale 
bar: 600 μm (Hr, RC3, Aldh1a1, 
and D2); 3 mm (Crym). (B) qPCR 
analysis was performed using 
forebrain homogenates from P21 
animals (n = 4–5 per genotype). 
Athyroid Pax8 KO mice were 
included and showed changes in 
forebrain gene expression similar 
to those of Mct8/Oatp1c1 DKO 
mice. These findings again point-
ed to a TH-deprived CNS in the 
absence of MCT8 and OATP1C1. 
*P < 0.05, **P < 0.01, ***P < 0.001 
vs. WT.
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was observed in Mct8/Oatp1c1 DKO mice only at P120, although 
a tendency toward higher numbers was already detectable at P12 
and P33 (Figure 7B). NeuN-labeled brain sections were used to 
quantify the thickness of the different cortical layers (Supplemen-
tal Figure 5B). Whereas layers V–VI exhibited similar thicknesses 
in animals of all genotypes (Supplemental Figure 5A), layers I–IV 
were significantly thinner in Mct8/Oatp1c1 DKO animals at all time 
points (Figure 7B). In summary, our immunohistochemical data 
pointed to persistent alterations in neuronal differentiation and 
cortical circuit formation in the absence of MCT8 and OATP1C1.
Mct8/Oatp1c1 DKO mice exhibit pronounced locomotor dysfunctions. 
As a first approach to assessing the neuromotor performance of 
TH transporter–mutant mice, we studied the gait of the animals 
by footprint analysis. Stride length was significantly reduced, and 
hind paw angle approximately 10° larger, in Mct8/Oatp1c1 DKO 
versus WT mice; conversely, Mct8 KO and Oatp1c1 KO animals 
exhibited gait parameters similar to those of WT controls (Figure 8, 
A and B). These alterations in stride length and hind paw angle 
were characteristic of cerebellar impairments and have also been 
found in other hypothyroid animal models (30).
To further examine locomotor behavior, we subjected 4-month-old 
mice (6–8 per genotype) to an accelerating rotarod test. After an ini-
tial training period under constant velocity, animals were tested on 5 
consecutive days for their ability to stay on the accelerating rod. With 
every day of testing, WT, Mct8 KO, and Oatp1c1 KO mice learned to 
stay for a longer time period on the rotating rod. In contrast, Mct8/
Oatp1c1 DKO mice did not improve their motor capabilities during 
the test period and fell down significantly earlier (Figure 8C).
Figure 6
Mct8/Oatp1c1 DKO mice display 
reduced myelination. (A) Frontal 
vibratome brain sections of male 
animals (n = 3 per genotype and 
time point) were stained with 
FluoroMyelin (FM), a dye that 
incorporates into myelin sheaths. 
Additionally, consecutive sec-
tions were stained with an anti-
body against MBP. Quantification 
of the fluorescence signal densi-
ties revealed reduced staining in 
Mct8/Oatp1c1 DKO mice at all 
time points (P12, P33, and P120). 
Scale bar: 600 μm. (B) Ultrathin 
sections of the medial part of 
the cc were analyzed by elec-
tron microscopy at P21 (n = 3). 
Compared with WT animals, 
the number of myelinated axons 
was visibly decreased in Mct8/
Oatp1c1 DKO mice as well as 
in athyroid Pax8 KO mice. How-
ever, the ultrastructure of the 
myelin sheaths appeared rather 
similar in all genotypes (higher-
magnification insets). Scale bars: 
5 μm (top); 500 nm (bottom); 
50 nm (insets). (C) P21 and 
P180 coronal paraffin brain sec-
tions subjected to Gallyas silver 
staining were used to quantify cc 
thickness at the cingulum bun-
dle (n = 3). Only Mct8/Oatp1c1 
DKO mice showed decreased 
cc thickness at either time point. 
*P < 0.05, **P < 0.01, ***P < 0.001 
vs. WT, or as otherwise indicated 
(brackets).
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Since the lower body weight of Mct8/Oatp1c1 DKO mice may con-
tribute to the poor rotarod performance, we repeated the experi-
ments in order to compare 5-month-old Mct8/Oatp1c1 DKO and 
Mct8 KO littermates with 2-month-old Mct8 KO mice, whose body 
weight was similar to that of the Mct8/Oatp1c1 DKO mice exam-
ined. Mct8 KO animals displayed similar rotarod performance, 
independent of age and body weight, whereas Mct8/Oatp1c1 DKO 
mice again fell off the rotating wheel very quickly (Supplemental 
Figure 7
Histological analysis of GABAergic neurons 
in the somatosensory cortex. Coronal fore-
brain vibratome sections from perfusion-
fixed male mice (n = 3 per genotype and time 
point) were immunostained with antibodies 
recognizing the calcium-binding proteins PV, 
CB, and CR; the neuronal transcription fac-
tor NeuN; and the GABA-producing enzyme 
GAD67. (A) Representative views demon-
strating visibly reduced P33, PV, and GAD67 
immunoreactivity in the somatosensory cor-
tex of Mct8/Oatp1c1 DKO mice. Scale bar: 
250 μm. (B) This optical impression was 
confirmed by measuring GAD67 integrated 
fluorescence signal density and counting 
PV-positive cells using ImageJ. Quantifica-
tion also revealed a slight increase in the 
number of CR-positive neurons in Mct8/
Oatp1c1 DKO mice. Thickness of the corti-
cal layers was determined in NeuN-stained 
brain sections and disclosed a thinner layer 
I–IV in Mct8/Oatp1c1 DKO mice. Overall, 
these data pointed to pronounced altera-
tions in the cortical GABAergic system in 
Mct8/Oatp1c1 DKO animals. *P < 0.05, 
**P < 0.01, ***P < 0.001 vs. WT, or as other-
wise indicated (brackets).
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Figure 6A). This finding rebutted the possibility of a major effect 
of reduced body weight on locomotor phenotype.
As another approach to monitoring locomotor disabilities and 
coordination impairments, animals were subjected to a beam walk 
test: 5-month-old mice (6–8 per genotype) were trained to cross a 
100-cm-long square beam 1 cm in width. The number of hind limb 
slips during the run was recorded, Mct8/Oatp1c1 DKO mice dis-
played twice as many slips as the other groups (Figure 8D). More-
over, Mct8/Oatp1c1 DKO mice also needed significantly more time 
to cross the beam (Supplemental Figure 6B). Overall, the results 
of both tests pointed to deficits in fine motor coordination and 
reduced locomotor activities in Mct8/Oatp1c1 DKO animals.
Next, a hanging wire test was performed in order to detect altera-
tions in grip strength. Animals were put on a metal wire that was 
turned upside-down for a maximum of 60 seconds (Figure 8E). 
WT and single-mutant mice managed to stay on the wire for the 
entire test period without any obvious problems; instead, they 
moved around and even groomed themselves. In contrast, Mct8/
Oatp1c1 DKO mice appeared immobile and rarely managed to stay 
on the wire longer than approximately 30 seconds, indicative of 
reduced grip strength. To substantiate the latter finding, we quan-
tified grip strength using a high-precision force sensor (Figure 8F). 
This test also revealed an approximately 35% reduction in forelimb 
grip strength in Mct8/Oatp1c1 DKO versus WT mice. These find-
ings suggested that animals with combined MCT8 and OATP1C1 
deficiency have pronounced neuromuscular disabilities.
Discussion
Because inactivating mutations in the TH transporter MCT8 
have been linked to AHDS, intensive research activities have been 
undertaken to clarify why MCT8 deficiency causes severe neuro-
logical symptoms and neuromuscular abnormalities in affected 
patients. These efforts were severely hampered by the fact that 
information regarding molecular and cellular abnormalities in the 
CNS of affected patients are still scarce, and that a suitable animal 
model replicating the phenotype of human MCT8 deficiency was 
not available. Although mice deficient in MCT8 revealed impor-
tant aspects regarding the role of MCT8 in peripheral tissues, such 
as liver, kidneys, and thyroid gland (11–13, 31–33), Mct8 KO mice 
did not show any overt neurological symptoms, calling this mouse 
model into question as an adequate model system for AHDS.
Here, we described the generation and first analysis of mouse 
mutants that lack the T4-specific transporter OATP1C1 in addi-
tion to MCT8. These Mct8/Oatp1c1 DKO mice fully replicated the 
abnormal serum TH profile (low T4, high T3, and elevated TSH) 
characteristic of MCT8 deficiency (Figure 1) and showed a state 
of hepatic and renal thyrotoxicosis similar to that of Mct8 KO ani-
mals (Supplemental Figure 2). However, in contrast to Mct8 KO 
mice, brain development and function was markedly impaired in 
the absence of both MCT8 and OATP1C1.
Previous studies in mice already revealed the unique function 
of MCT8 in mediating the passage of T3 into the CNS, whereas 
T4 transport was found to be mildly affected in the absence of 
MCT8 (12, 14). At first glance, this finding was rather surpris-
ing, since in in vitro assays, MCT8 has been shown to transport 
T3 and T4 equally well (1). This discrepancy led to the hypoth-
esis that mice express another T4-specific transporter at the BBB 
and/or BCSFB that ensures delivery of T4 to the CNS, even in 
the absence of MCT8. That this T4-specific transporter is indeed 
OATP1C1 was demonstrated unequivocally by our current in 
vivo uptake studies. Only Mct8/Oatp1c1 DKO mice exhibited 
highly diminished passage of peripherally injected T4 into the 
brain, whereas T4 transport in Mct8 KO and Oatp1c1 KO mice was 
reduced to only about 50% of the WT value (Figure 3). Thus, at 
Figure 8
Abnormal gait and severe locomotor deficiencies 
in Mct8/Oatp1c1 DKO mice. Mct8/Oatp1c1 DKO 
animals exhibited abnormal gait, as demonstrated 
by significantly reduced stride length (A), and a 
strongly elevated hind paw angle (B) based on 
footprint analysis. (C) Locomotor deficiencies were 
monitored by a rotarod test using 4-month-old male 
mice (n = 6–8 per genotype). In contrast to WT, Mct8 
KO, and Oatp1c1 KO animals, Mct8/Oatp1c1 DKO 
mice performed poorly on the rod and did not show 
a learning curve. #P < 0.001 vs. WT. (D) In order to 
assess balance and coordination, mice were moni-
tored while running on a beam 1 cm wide and 100 
cm long. Recording the hind limb slips revealed a 
significantly higher number of errors only in Mct8/
Oatp1c1 DKO mice. (E) Mice were further sub-
jected to a hanging wire test in order to determine 
neuromuscular abnormalities. Only Mct8/Oatp1c1 
DKO mice were not able to cling on a metal wire for 
60 seconds. (F) As these findings point to reduced 
muscle performance, forepaw muscle strength was 
quantified using a grip strength meter, revealing an 
approximately 35% reduction in Mct8/Oatp1c1 DKO 
animals. *P < 0.05, **P < 0.01, ***P < 0.001 vs. WT, 
or as otherwise indicated (brackets).
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least in the mouse CNS, MCT8 and OATP1C1 mediate the access 
of TH to the brain.
Although brain TH content was drastically reduced, 10% of WT 
T3 and T4 levels were still detected in brain homogenates of Mct8/
Oatp1c1 DKO mice (Figure 4). Since animals were perfused with 
PBS before tissue collection, it is not likely that the TH concen-
trations found in these brain homogenates only reflect blood con-
taminations. As one possible explanation, combined MCT8 and 
OATP1C1 deficiency may not primarily affect the import of TH 
into capillary endothelial cells, but rather compromise the efflux of 
TH from endothelial cells into the brain parenchyme and/or astro-
cytes. Notably, the L-type amino acid transporter LAT1 (encoded 
by Slc7a5) is highly expressed in endothelial cells of the BBB, where 
it localizes to the luminal site (34). Since LAT1 efficiently trans-
ports not only large neutral amino acids, but also TH (35), capil-
lary endothelial cells may still contain significant amounts of TH, 
even in the absence of MCT8 and OATP1C1. Future studies com-
bining LAT1-mutant mice with animals lacking both MCT8 and 
OATP1C1 should provide further information in this regard.
We demonstrated by several experimental approaches that astro-
cytes and neurons of Mct8/Oatp1c1 DKO mice were clearly defi-
cient in TH. Expression of the astrocytic enzyme D2, which is neg-
atively regulated by T3 at the transcriptional level and even more 
so by T4 at the posttranslational level, was highly increased in the 
brains of Mct8/Oatp1c1 DKO animals, indicative of a pronounced 
hypothyroid state of astrocytes. Moreover, the transcript levels of 
several genes known to be positively regulated by TH in distinct 
subsets of neurons were strongly reduced, to an extent similar to 
those in athyroid Pax8 KO animals (Figure 5B). ISH studies also 
revealed that the hypothalamic transcript levels of Trh, which were 
already elevated in Mct8 KO animals, were even further increased in 
Mct8/Oatp1c1 DKO mice (Figure 2), which indicated that the nega-
tive feedback loop of the HPT axis is strongly compromised. Based 
on this observation, it is reasonable to assume that Mct8/Oatp1c1 
DKO animals exhibit a central resistance to TH, similar to patients 
with MCT8 mutations (36).
Congenital hypothyroidism in rodents is linked to various mor-
phological alterations in neuronal maturation, of which retarded 
cerebellar development is a prominent and well-studied example 
(37–40). During TH deficiency, the differentiation of basically all 
cerebellar cell types is delayed. Consequently, the formation of 
synaptic contacts, which requires a highly synchronized pattern of 
dendritic and axonal growth, is persistently diminished. A striking 
hallmark of a congenitally hypothyroid cerebellum is a poorly devel-
oped PC with stunted dendrites, a feature that was also observed in 
Mct8/Oatp1c1 DKO animals (Supplemental Figure 4A). As the cer-
ebellum represents an important brain area for fine motor control, 
cerebellar dysfunction is linked to pronounced locomotor deficits, 
such as ataxia, poor coordination, and incorrectly timed movement. 
In agreement with disturbed cerebellar development, Mct8/Oatp1c1 
DKO mice exhibited abnormal gait and poor coordination (Figure 8, 
A–D). Even reduced grip strength, which was a prominent feature of 
the Mct8/Oatp1c1 DKO mice (Figure 8F), may be related to cerebellar 
dysfunction, although abnormalities in neuromuscular transmis-
sion cannot be ruled out.
Impaired myelinogenesis is another hallmark of TH deficiency. 
TH controls the timing of oligodendrocyte development, as it 
induces oligodendrocyte precursor cells to initiate differentiation 
processes (41, 42). Moreover, the expression of several myelin-
associated proteins, such as MBP, proteolipid protein, or myelin-
associated glycoprotein, are directly regulated by TH (43, 44). 
Therefore, it is not too surprising that, as a result of low TH levels 
in the CNS, Mct8/Oatp1c1 DKO mice exhibited reduced myelina-
tion caused by reduced white matter tract size, as illustrated by 
silver stainings (Figure 6 and Supplemental Figure 4B). Such a 
myelination deficit is expected to compromise neuronal conduc-
tance and may also contribute to the locomotor impairments and 
neuromuscular deficits observed in Mct8/Oatp1c1 DKO animals.
In addition to these findings, Mct8/Oatp1c1 DKO mice exhib-
ited rather surprising abnormalities in the cerebral cortex, where 
immunohistochemical analysis revealed a pronounced and persis-
tent reduction in GAD67 immunoreactivity (Figure 7, A and B), 
which indicated that the inhibitory cortical GABAergic system is 
strongly affected. These changes were not restricted to the somato-
sensory area, but were also observed in other cortical regions, such 
as the motor and the retrosplenial cortex. In previous studies, TH 
insufficiency during brain development has been demonstrated to 
reduce PV immunoreactivity in the cerebral cortex of rats (28, 29), 
which suggests that only a subgroup of inhibitory interneurons 
characterized by PV expression — so-called basket and chandelier 
cells — is sensitive to TH deprivation. Likewise, mouse mutants 
expressing a dominant-negative TRα1 protein show only a tran-
sient reduction in cortical PV immunoreactivity that normal-
izes after weaning (30). In contrast, PV expression in adult Mct8/ 
Oatp1c1 DKO mice remained low compared with the respective 
controls. Moreover, unlike TRα1-mutant animals, Mct8/Oatp1c1 
DKO mice displayed alterations in GAD67 immunoreactivity. 
Decreased cortical GAD expression has only been reported once 
for hypothyroid rats (45), which suggests that the phenotype of 
our TH transporter–deficient mice is rather unique.
Cortical GABAergic dysfunction has been linked to the patho-
physiology of various psychiatric disorders, such as schizophrenia, 
bipolar disorder, and autism (46, 47). PV-positive, fast-spiking 
interneurons are critically involved in synchronizing the activity of 
pyramidal neurons and are therefore considered as a key GABA ergic 
system responsible for the control of cortical output (48). Reduced 
expression of the calcium-binding protein PV leads to asynchro-
nous release of GABA, thereby affecting cortical network oscilla-
tions (49). Decreased expression of GAD67, the main GABA-syn-
thesizing enzyme in the CNS, will not only compromise inhibitory 
transmission, but also affect the maturation of inhibitory synapses, 
a process that is initiated after the first postnatal week. It is there-
fore conceivable that in the absence of both MCT8 and OATP1C1, 
development of the cortical inhibitory system is impaired, which in 
turn causes augmented and putatively unsynchronized activity of 
excitatory cortical neurons. The latter hypothesis, however, needs 
to be further tested by electrophysiological studies.
It also remains to be investigated to what extent the neural 
abnormalities observed in Mct8/Oatp1c1 DKO mice can be fully 
explained by impaired transport of TH via the BBB and/or BCSFB, 
or whether the contribution of additional factors must be con-
sidered. During prenatal development, both TH transporters 
are present in neuronal precursor cells of the ventricular zone. 
In fact, analysis of a mouse line expressing an Oatp1c1 promoter 
construct–driven cre recombinase and a Rosa26 reporter con-
struct revealed that the Oatp1c1 promoter is temporarily active in 
neuronal precursor cells that later develop into a distinct subset of 
cortical neurons residing in layer 2/3 (50). It is tempting to assume 
that these neurons might show enhanced sensitivity to alterations 
in TH levels and that concomitant genetic inactivation of Mct8 
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activities were rapidly frozen on dry ice and stored at –80°C. For determi-
nation of forebrain TH content, animals (n = 8 per genotype) at P21 were 
deeply anesthetized with isoflurane and perfused intracardially with PBS. 
Forebrains were rapidly frozen on dry ice and stored at –80°C. Male mice 
at P12, P33, and P120 destined for immunohistochemical analysis (n = 3 
per genotype and time point) were deeply anesthetized with isoflurane and 
subjected to intracardial perfusion fixation using a solution of 4% PFA in 
PBS. Whole brains were removed and postfixed for 24 hours with 4% PFA 
in PBS. Thereafter, brains were washed 3 times in PBS and stored in PBS 
containing 0.4% sodium azide at 4°C until further processing. See Supple-
mental Methods for details on animal genotyping.
ISH histochemistry. cDNA fragments corresponding to nt 1,380–1,941 
of mouse Aldh1a1 (GenBank accession no. NM_013467.3), nt 489–1,005 
of mouse Crym (NM_016669), nt 40–1,055 of mouse D1 (NM_007860), 
nt 131–1,045 of mouse D2 (NM_010050.2), nt 248–445 of mouse Gh 
(NM_008117.2), nt 125–402 of mouse Ghrh (NM_010285.2), nt 902–1,598 
of mouse Hr (NM_021877.2), nt 137–629 of mouse Igf1 (NM_010512), 
nt 498–1,005 of mouse RC3 (NM_022029.2), nt 42–557 of mouse Sst 
(NM_009215), nt 1,251–1,876 of mouse Trh (NM_009426.2), and nt 
190–445 of mouse Tshb (NM_009432.2) were generated by PCR and sub-
cloned into the pGEM-T Easy Vector (Promega). Radiolabeled riboprobes 
were generated by in vitro transcription using [35S]UTP as labeled sub-
strate (Hartmann Analytik). ISH was carried out as described previously 
(51). In brief, frozen sections were air-dried, followed by a 1-hour fixation 
in a 4% phosphate-buffered PFA solution (pH 7.4), and then permeabi-
lized by incubation in PBS containing 0.4% Triton X-100 for 10 minutes. 
Acetylation was carried out in 0.1 M triethanolamine (pH 8.0) containing 
0.25% (v/v) acetic anhydride. Sections were dehydrated, then covered with 
hybridization mix containing cRNA probes diluted in hybridization buffer 
(50% formamide, 10% dextran sulfate, 0.6 M NaCl, 10 mM Tris-HCl pH 7.5, 
1× Denhardt’s solution, 100 μg/ml sonicated salmon sperm DNA, 
1 mM EDTA, and 0.5 mg/ml t-RNA). 35S-labeled riboprobes were diluted 
in hybridization buffer to a final concentration of 1 × 104 cpm/μl. Prior 
to application, radioactive riboprobes for Gh, Trh, and Tshb were diluted 
with unlabeled riboprobes (5 ng/μl in hybridization buffer) at ratios of 
1:10, 10:1, and 3:1, respectively. Hybridization was performed overnight 
at 58°C. Slides were rinsed in 2× standard saline citrate (0.3 M NaCl and 
0.03 M sodium citrate, pH 7.0) and subsequently treated with ribonucle-
ase A/T1 at 37°C for 30 minutes. Final washes were carried out in 0.2× 
standard saline citrate at 65°C for 1 hour. For detection of radioactive ISH 
signals, sections were dehydrated and then exposed to X-ray films (BioMax 
MR; Eastman Kodak Co.) for 24 hours. Subsequently, sections were dipped 
in Kodak NTB nuclear emulsion (Kodak) and stored at 4°C for 8 (Aldh1a1, 
D2, and Hr), 5 (Crym and Ghrh), 4 (D1), 3 (Gh, Sst, Trh, and Tshb), or 2 (RC3) 
days. Autoradiograms were developed and analyzed under darkfield illumi-
nation. Experiments carried out using the respective sense probes did not 
produce any ISH signals.
TH, TSH, D2, and D3 activity. Serum T4 and T3 were determined by RIA 
in P21 animals (n = 8 per genotype) as reported previously (52). Brain T4 
and T3 content was measured after extraction of the tissues, as described in 
detail by Reyns et al. (53). D2 and D3 activities in cerebella and forebrains, 
as well as D2 activities in pituitary extracts, were assessed as reported previ-
ously (52). Briefly, tissues were homogenized in PED10 buffer, and protein 
concentration was determined by the Bradford method. For D2 activity 
analysis, homogenate dilutions were incubated with 2 × 105 cpm [125I]T4 
in the presence of unlabeled T3. D3 activities were assessed by incubat-
ing homogenate dilutions with 2 × 105 cpm [125I]T3. After 30 minutes at 
37 °C, reactions were stopped by adding ice-cold ethanol. After centrifu-
gation, supernatants were mixed with 0.02 M ammonium acetate (pH 4) 
and subjected to HPLC analysis. Radioactivity was monitored using a 
and Oatp1c1 may greatly interfere with their differentiation. Such 
cell-specific effects of combined MCT8 and OATP1C1 deficiency 
might eventually explain, at least in part, the CNS-specific differ-
ences between Mct8/Oatp1c1 DKO mice and TRα1-mutant animals 
and may also answer the question of why Mct8/Oatp1c1 DKO mice 
exhibited reduced thickness of the outer cortical layers (Figure 7B). 
Future studies using conditional MCT8 and OATP1C1–mutant 
mice crossed with a tamoxifen-inducible cre line driven by the 
Oatp1c1 promoter should reveal to what extent the simultaneous 
inactivation of MCT8 and OATP1C1, either at prenatal or at post-
natal stages, impairs brain development.
In summary, the Mct8/Oatp1c1 DKO mouse represents the first 
animal model showing pronounced TH deficiency in the CNS 
despite highly elevated T3 concentrations in the circulation, there-
by underscoring the physiological importance of TH transporters 
in providing the brain with sufficient amounts of TH. Unlike sin-
gle-mutant Mct8 KO and Oatp1c1 KO animals, Mct8/Oatp1c1 DKO 
mice displayed CNS-specific deficits, such as myelination deficits 
and pronounced locomotor impairments, that have also been 
observed in patients. To what extent the Mct8/Oatp1c1 DKO mouse 
fully replicates the clinical picture of human MCT8 deficiency 
cannot presently be assessed, as a biochemical and histopatho-
logical analysis of postmortem brain samples of patients has not 
been reported yet, and even functional MRI data are scarce. Still, 
Mct8/Oatp1c1 DKO mice can be considered as the animal model 
most closely reflecting human MCT8 deficiency. Consequently, 
we expect detailed studies of pre- and postnatal brain develop-
ment in these mice to provide further insights on the molecular 
mechanisms by which TH influences early events in neuronal dif-
ferentiation or regulates neuromuscular performance. Moreover, 
Mct8/Oatp1c1 DKO mice can serve as a valuable tool for testing the 
efficacy of putative therapeutic interventions in preventing brain 
damage, since TH treatment is not a useful option for patients 
with MCT8 deficiency.
Methods
Animals. Mct8 KO mice were obtained from Deltagen and have been 
described previously (12). Oatp1c1fl/fl mice were generated at TaconicArte-
mis and mated with a germline deleter cre mouse line in order to obtain 
Oatp1c1 KO mice. The targeting strategy, generation, and analysis of 
Oatp1c1 KO animals has been published recently (19). Mct8–/(–) Oatp1c1+/– 
breeding pairs (C57BL/6 background) were used to generate Mct8/Oatp1c1 
DKO and Mct8 KO mice. Oatp1c1+/– matings (C57BL/6 background) were 
set up to obtain Oatp1c1 KO mice and WT littermates. Pax8 KO mice 
(mixed background) were generated by breeding Pax8+/– animals (20). All 
mice were provided with standard laboratory chow and tap water ad libi-
tum and were kept at constant temperature (22°C) and controlled light 
cycle (12-hour light/12-hour dark).
The body weight of 16 litters (5–8 newborn per litter) was monitored 
daily for the first 3 postnatal weeks. Female and male mice at P21 were 
killed by CO2 in order to collect serum samples for TH and TSH deter-
mination. In addition, forebrains, kidneys, and pieces of liver designated 
for ISH analysis were frozen in isopentane cooled on dry ice. Pituitaries 
were embedded in OCT medium (Sakura Finetek) before being frozen on 
dry ice. For timeline ISH studies, male mice at P6 and P12 were killed by 
decapitation, whereas animals at P21 and P33 were killed by CO2, and tis-
sues were prepared as described above (n = 4 per genotype and time point). 
Cryosections of coronal forebrain, liver, and kidney (20 μm) as well as pitu-
itaries (16 μm) were thaw-mounted on superfrost slides (Thermo Scientif-
ic). Tissues designated for qPCR analysis and measurement of deiodinase 
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GAD1 antibody (1:40 R&D Systems) was used after blocking the respec-
tive tissue sections with 10% donkey serum diluted in PBS containing 0.2% 
Triton X-100. Subsequently, sections were incubated with respective Alexa 
Fluor 488– or Alexa Fluor 555–labeled secondary antibodies (Invitrogen) 
and with Hoechst33258 (1:10,000; Invitrogen) to label cell nuclei. The 
BrainStain Imaging Kit (Invitrogen) was used to assess the myelin content 
in 50 μm coronal forebrain vibratome sections according to the manufac-
turer’s protocol. Briefly, sections were permeabilized for 30 minutes in PBS 
containing 0.2% Triton X-100, then stained with Fluoro Myelin green dye 
(1:300) and DAPI (1:300) in PBS. See Supplemental Methods for details 
on staining quantification, processing of brain tissue for EM analysis, and 
Gallyas and Bielschowsky silver staining.
Gait analysis, rotarod, and beam walk test. See Supplemental Methods.
Statistics. Values represent mean and SEM from at least 3 animals per gen-
otype. For multigroup comparisons, 2-way ANOVA was performed (2 × 2 
factorial ANOVA; factor A, WT vs. Oatp1c1 KO; factor B, WT vs. Mct8 KO) 
using Daniels XL Toolbox packet for Microsoft Excel. When P values less 
than 0.05 were received, pairwise comparison between individual groups 
was done followed by Bonferroni post-hoc testing using Microsoft Excel. 
A P value less than 0.05 was considered significant.
Study approval. Animal experiments were approved by the local animal 
welfare committees (TLLV Thüringen, Bad Langensalza, Germany).
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flow scintillation detector (Radiomatic A-500; Packard). TSH serum levels 
were determined using a double-antibody precipitation RIA as previously 
described (54, 55). Briefly, 25 μl mouse serum, 25 μl PBS containing 0.1% 
azide, and 100 μl (final dilution, 1:25,000) rabbit anti-rat TSH serum (anti-rat 
TSH RIA-6; NIDDK) were incubated for 4 hours at RT. Subsequently, 100 μl 
[125I]rTSH tracer (approximately 15,000 cpm; MP Biomedicals) was added, 
and the mixture was incubated overnight at RT to allow equilibration. Next, 
500 μl donkey anti-rabbit secondary antibody coated onto magnetizable 
polymer beads (Amerlex M; GE Healthcare) was added, mixed, and incubated 
at RT for 15 minutes. Samples were centrifuged for 15 minutes at 756 g at 
RT, and the pellets were counted and calculated using Wizard γ counter and 
RiaSmart software (Perkin Elmer). Mouse standards were prepared by serial 
dilution of serum pool with high murine TSH (mTSH) with mTSH-0 serum, 
as described previously (54), and samples were assayed in duplicate.
In vivo transport studies. Uptake analysis was carried out by injecting 2.5- to 
4.5-month-old male animals (n ≥ 3 per genotype and time point) i.p. with 
1.2 μCi [125I]T4 (PerkinElmer) in PBS. For injection as well as perfusion, 
mice were deeply anesthetized with isoflurane. After collecting heart blood, 
mice were intracardially perfused with PBS, after which brains, livers, and 
kidneys were collected. To determine the amount of radioactivity taken up 
by different tissues, organs and blood samples were weighed, and radioac-
tivity was measured in an automatic γ counter.
qPCR. Total tissue RNA was isolated using the NucleoSpin RNA II Kit 
(Macherey-Nagel). Synthesis of cDNA was performed using the Transcriptor 
High Fidelity cDNA Synthesis Kit (Roche). To exclude the presence of genom-
ic DNA, 1 sample without reverse transcriptase was included as well. qPCR 
was performed using iQ SYBR Green Supermix and Multicolor Real-Time 
PCR Detection System (Bio-Rad). At least 5 samples per genotype were sub-
jected to analysis. As a housekeeping gene for normalization, cyclophilin D 
(CycD) was used. See Supplemental Methods for primer sequences.
Immunohistochemistry. Perfusion-fixed 50 μm forebrain (frontal) and cer-
ebellum (sagittal) sections of P12, P33, and P120 male mice were cut on a 
vibratome (Microm). Sections were blocked and permeabilized with 10% 
normal goat serum in PBS containing 0.2% Triton X-100. Cerebellar sec-
tions were stained with a monoclonal mouse anti-CB antibody (1:1,000; 
Swant), followed by incubation with an Alexa Fluor 555–labeled goat 
anti-rabbit secondary antibody (Invitrogen) and analysis with a Zeiss Axio 
Imager Z1 (Zeiss). Consecutive forebrain sections were stained with the fol-
lowing antibodies (all from Millipore): rabbit anti-CB (1:500), rabbit anti-
CR (1:500), mouse anti-GAD67 (1:200), rat anti-MBP (1:200), mouse anti-
NeuN (1:500), and mouse anti-PV (1:1,000). In addition, a goat anti-human 
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